Ram. Lipopolysaccharide induces relaxation in lung pericytes by an iNOS-independent mechanism. Am J Physiol Lung Cell Mol Physiol 278: L880-L887, 2000.-Lipopolysaccharide (LPS)-regulated contractility in pericytes may play an important role in mediating pulmonary microvascular fluid hemodynamics during inflammation and sepsis. LPS has been shown to regulate inducible nitric oxide (NO) synthase (iNOS) in various cell types, leading to NO generation, which is associated with vasodilatation. The purpose of this study was to test the hypothesis that LPS can regulate relaxation in lung pericytes and to determine whether this relaxation is mediated through the iNOS pathway. As predicted, LPS stimulated NO synthesis and reduced basal tension by 49% (P Ͻ 0.001). However, the NO synthase inhibitors N -nitro-L-arginine methyl ester, aminoguanidine, and N -monomethyl-L-arginine did not block the relaxation produced by LPS. In fact, aminoguanidine and N -monomethyl-L-arginine potentiated the LPS response. The possibility that NO might mediate either contraction or relaxation of the pericyte was further investigated through the use of NO donor compounds; however, neither sodium nitroprusside nor S-nitroso-N-acetylpenicillamine had any significant effect on pericyte contraction. The inhibitory effect of aminoguanidine on LPS-stimulated NO production was confirmed. This ability of LPS to inhibit contractility independent of iNOS was also demonstrated in lung pericytes derived from iNOSdeficient mice. This suggests the presence of an iNOSindependent but as yet undetermined pathway by which lung pericyte contractility is regulated. nitric oxide; sepsis; inducible nitric oxide synthase ABNORMALITIES IN CAPILLARY permeability are hallmarks of inflammation and can lead to extravascular fluid sequestration. It has been proposed that mediators of edema increase permeability by altering the contractile state of either the smooth muscle cell or the pericyte within the vascular wall. Because increases in vascular permeability have been shown to exist in capillaries or venules that have no smooth muscle, pericyte contractility may be a factor in this response. This hypothesis has since been supported by several studies involving both morphological (3, 32) and microscopic (27) analyses. For example, Majno et al. (18) proposed that mediators of edema produced contractions within the cremaster microvessels, which created gaps of up to 1 µm in diameter that allowed leakage of macromolecules into the interstitium. Others (4, 9) have also observed similar findings of gap formation in the presence of histamine. Other investigators (3, 7, 10) have demonstrated very potent capillary constrictor effects by mediators of edema, resulting in increased capillary permeability. Whether the pericyte exerts its effect on microvascular permeability through regulation of perfusion pressure, intercellular gap junction formation, or both is still a matter of debate. Thus there is both in vitro and in vivo data to support the association of pericyte contraction and microvascular permeability. Therefore, investigation of mechanisms regulating pericyte contraction is of interest.
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In the clinical setting, loss of capillary permeability regulation can lead to extravascular interstitial fluid accumulation in the lungs as seen in acute respiratory distress syndrome (ARDS), one possible sequela of the systemic inflammatory response syndrome (SIRS). Because pericytes could mediate these changes in capillary permeability, contractile responses of the pericyte may be a linchpin in this and other clinical pathophysiological conditions involving capillary dysfunction, such as hypertension and diabetes.
Lipopolysaccharide (LPS) is a proximal mediator in the initiation of sepsis as well as of local inflammation and is a potent stimulus of other inflammatory mediators, including nitric oxide (NO). NO is a key player in the cytokine cascade, which has been shown in vivo to be capable of producing peripheral hypotension. In vitro studies have also demonstrated the ability of NO to relax both smooth muscle cells (22, 24) and retinal pericytes (11) , which suggests that NO may play an important role in regulating blood pressure as well as microvascular permeability. One mechanism in which LPS stimulates NO production is by upregulating inducible NO synthase (iNOS) in vascular tissue (37) . Many cells within the vasculature are capable of expressing iNOS (15, 19, 20, 28, 33) , including endothelium, smooth muscle, and mesangial cells. A recent study (16) has demonstrated the ability of LPS to attenuate KCl-stimulated contractile responses of smooth muscle cells in vitro through an iNOS-dependent mechanism. In another study (31) , LPS was also capable of attenuating KCl-stimulated contractile responses in both mammary arteries and saphenous veins. The aim of this study was to determine whether LPS can affect lung pericyte contractility and, if so, whether this effect is mediated through iNOS. To determine iNOS involvement, the ability of the NOS inhibitors aminoguanidine, N -nitro-L-arginine methyl ester (L-NAME), and N -monomethyl-L-arginine (L-NMMA) to attenuate the LPS response was examined. Nitrate and nitrite production was also measured as an indicator of NOS activity. In addition, the ability of LPS to affect contractility in iNOS-deficient mice was examined to demonstrate, nonpharmacologically, that LPS reduces pericyte contractility independent of iNOS.
MATERIALS AND METHODS
Culture and characterization of lung pericytes. Pericytes were isolated from rat lungs as previously described (8) and modified by this laboratory (30) to account for the complexity of lung tissue. Briefly, male Sprague-Dawley rats (250-274 g; Harlan, Indianapolis, IN) were killed by lethal injection of pentobarbital sodium (120 mg/kg) in accordance with the National Institutes of Health guidelines and approved by the Animal Investigation Committee of Wayne State University (Detroit, MI). Each lung was dissected out and rinsed with calcium-and magnesium-free PBS. To avoid possible smooth muscle cell contamination, only the outer 2-mm peripheral portion of the lung was removed. The tissue was minced with scissors and incubated at 37°C for 20 min in 10 ml of PBS containing 1,000 U/ml collagenase type I, 0.5% BSA, 2 U/ml pronase E, and 0.5 U/ml DNase (all purchased from Sigma, St. Louis, MO). After the initial incubation, the tissue was homogenized with two strokes of a pestle to loosen microvessel fragments and incubated for an additional 10 min. The resulting suspension was filtered through a 100-µm nylon mesh to remove large tissue fragments and washed with DMEM containing 10% fetal bovine serum (FBS) and 0.5% antibiotic-antimycotic solution (ABX) (all purchased from GIBCO BRL, Life Technologies, Gaithersburg, MD). After being washed, the cell pellet was resuspended in 10 ml of red blood cell lysis buffer (Sigma) for 10 min at 4°C, washed two more times, and resuspended in uncoated tissue culture dishes in DMEM supplemented with 10% platelet-deficient serum (PDS; Sigma) and 0.5% ABX at a cell concentration of ϳ10 6 cells/60-mm dish.
Supplementation of PDS in place of FBS allowed the preferential selection of pericytes so that by second or third passage, only pericytes remained. Once a homogeneous culture of pericytes was obtained, FBS was added to the pericyte plating medium in place of PDS to provide the growth factors necessary for proliferation of the pericytes. Only cells in passages 2 through 7 were used.
Male C57BL /6 (control) and C57BL /6-Nos2 (iNOS-deficient) mice were purchased from Jackson Laboratories (Bar Harbor, ME) and killed by lethal injection of pentobarbital sodium (120 mg/kg) in accordance with the National Institutes of Health guidelines and approved by the Animal Investigation Committee of Wayne State University. The pericytes were isolated from the mouse lungs in the same manner as described above for rats except that tissues from four mice were combined and treated as one. Only cells in passages 2 through 4 were used.
The identity of the pericytes was confirmed by the presence of smooth muscle actin (29) observed by indirect immunofluorescent microscopy with monoclonal anti-␣-smooth muscle actin (Sigma) and by their inability to phagocytose acetylated low-density lipoprotein (Ac-LDL) labeled with 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate (Biomedical Technologies, Stoughton, MA). This differentiates them from endothelial cells and macrophages, which avidly endocytose Ac-LDL via their scavenger receptors (34) . Morphologically, pericytes can be distinguished from other cells of the microvasculature by their large, irregular shape with dendritic processes and the lack of the hill-and-valley morphology typical of smooth muscle cells at confluency. To further differentiate smooth muscle cells from pericytes, the average resting membrane potential of pericytes from the various rat cultures was determined to be approximately Ϫ30 mV (J. Herskovic, personal communication), which is consistent with that observed by others in studies involving retinal pericytes (2, 35) .
Contractility assays. Three-dimensional collagen gel matrices were prepared as previously described (13) and modified (30) . Collagen type I (Pancogene S, Gattefosse, Westwood, NJ) was dialyzed in 1% (vol/vol) acetic acid for 36 h and stored at 4°C as stock (3 mg/ml). To prepare the gels, stock collagen was added to plating medium (DMEM containing 10% FBS and 0.5% ABX) at a ratio of 1:3, mixed rapidly, plated into 24-well plates (0.5 ml/well), and incubated at 37°C for 15 min to allow the collagen to polymerize. Cultured pericytes were then passaged with 0.125% trypsin-0.02% EDTA (GIBCO BRL), plated on top of the collagen gels at a concentration of 7.5 ϫ 10 4 cells/well in plating medium (0.5 ml/well) unless otherwise noted, and incubated for 24 h at 37°C and 5% CO 2 .
After 24 h, the medium was removed from the wells by inverting the wells over a paper towel in a sterile hood. For the LPS assays, the cells were rinsed and resuspended in assay medium (DMEM containing 400 µM L-arginine) with 15 µM BSA in the presence of various LPS concentrations (0-100 µg/ml) for 24 or 48 h at 37°C and 5% CO 2 . To test the effects of the NOS inhibitors, cells were incubated with 0-100 µg/ml LPS in the presence and absence of 200 µM aminoguanidine (RBI, Natick, MA), 200 µM L-NMMA (RBI), or 10 µM L-NAME (Sigma) for the entire incubation. All solutions were prepared just before use. For assays involving bradykinin (control agent; Sigma) and the NO donors spermine NONOate (Cayman Chemical, Ann Arbor, MI), sodium nitroprusside (SNP; Sigma), and S-nitroso-N-acetylpenicillamine (SNAP; RBI), a stock solution was prepared just before use by dilution in assay medium. Dilutions were added as 10ϫ the final concentration and allowed to incubate for 10 min before the gels were detached from the sides of the well.
On the day of assay, the gels were detached from the sides of their wells and photographs were taken at 10-min intervals, up to 60 min, with the aid of a macro lens. Collagen surface area was measured with Digitizer software, and contraction is expressed as percentage of the initial surface area. Results are expressed as percent change in contraction from the control value (no LPS). For measurement of NO production, medium supernatants were removed immediately after the 10-min time point was photographed and stored at Ϫ20°C until assayed.
Because cell density has been shown to affect pericytedependent contraction of collagen gel matrices (13, 30) and LPS has been shown to affect proliferation in certain cell types (6), cell density was determined in some of the assays after incubation in LPS with and without the various NOS inhibitors. To do this, collagen gels were digested in a 10 mg/ml collagenase type I (GIBCO BRL) enzyme solution. After a 30-min incubation in the collagenase solution, the cell suspensions from the wells treated in triplicate were combined, washed in PBS, and counted with the aid of a hemocytometer.
Determination of NO production. NO production was measured in the supernatants from LPS-treated cells after both 24-and 48-h incubations by use of a nitrate/nitrite colorimetric assay kit (Cayman Chemical). Briefly, 80-µl aliquots of supernatant were incubated in nitrate reductase solution containing the necessary cofactors required for conversion of nitrates to nitrites, and combined nitrate and nitrite was measured with Griess reagents, which react with nitrite to form a purple azo compound with an absorbance at 543 nm. Standards were prepared in assay medium with a sample detection limit of 2.5 µM. The cells were resuspended in 0.1 M NaOH after collagenase treatment, and protein content was determined by the Bio-Rad Bradford technique for normalization of nitrite per milligram of protein.
Statistical analysis. Results are expressed as means Ϯ SE unless otherwise noted. For contractility assays, error bars for the control values represent the average SE of triplicate measurements for each experiment. For all assays, statistical analysis was performed with a one-way repeated-measures ANOVA followed by a multiple comparison procedure with the Student-Newman-Keuls method. A value of P Ͻ 0.05 was considered significant.
RESULTS
Effects of LPS on rat lung pericyte contractility. As we expected, incubation of pericytes with LPS significantly reduced contractility of the pericytes in a concentrationdependent manner. LPS-induced relaxation (i.e., decreased contraction) was evident by 24 h and still present when tested at 48 h (Fig. 1) . At the highest concentration tested (100 µg/ml), LPS maximally reduced contraction by 49 Ϯ 4 and 42 Ϯ 6% at 24 and 48 h, respectively. LPS-induced relaxation did not occur with shorter incubations (10 min to 1 h, data not shown).
Effects of aminoguanidine on LPS-induced relaxation and NO production. To determine whether iNOS was involved in mediating the LPS-induced relaxation, pericytes were treated with LPS and incubated for 24 or 48 h in the presence and absence of aminoguanidine, a noncompetitive inhibitor of iNOS, and nitrite measurements were taken from the supernatant medium. NO production was not detectable in the 24-h contractility assay with the colorimetric assay kit; however, by 48 h, NO production was evident and significantly upregulated in the LPS-treated cultures in a concentrationdependent manner (Fig. 2 ). In the presence of 100 µg/ml LPS, NO production was increased ϳ90% (P Ͻ 0.05) over the control (no LPS, no aminoguanidine) value. As expected, aminoguanidine (200 µM) reduced NO levels, significantly decreasing NO synthesis by ϳ50% (P Ͻ 0.05) in control (no LPS) cells and in the presence of 100 µg/ml LPS. The ability of LPS to induce relaxation in these assays was not blocked by aminoguanidine (Fig. 3) . In fact, in the presence of aminoguanidine for 48 h, 50 and 100 µg/ml LPS reduced contraction in the pericytes by 71 Ϯ 4 and 76 Ϯ 4%, respectively, which was significantly greater than LPS alone. This same effect was also present after 24 h. In the presence of aminoguanidine, 50 and 100 µg/ml LPS decreased contraction of pericytes by 66 Ϯ 5 and 71 Ϯ 6%, respectively, which was also significantly greater than that of LPS alone.
Effect of L-NAME and L-NMMA on LPS-induced relaxation. To determine whether this increase in LPSinduced relaxation of pericytes was a general property of NO synthesis inhibitors, the ability of the NOS inhibitors L-NMMA and L-NAME to affect LPS-induced relaxation of pericytes was also tested (Fig. 4) . As with aminoguanidine, neither of these NOS inhibitors blocked the LPS-induced relaxation. In the presence of L-NMMA (200 µM), LPS at concentrations of 50 and 100 µg/ml decreased contraction of the pericytes by 73 Ϯ 7 and 75 Ϯ 7%, respectively, which was significantly greater than LPS alone at these concentrations. In the presence of L-NAME (10 µM), LPS decreased contraction in the pericytes by 61 Ϯ 4 and 67 Ϯ 4% at 50 and 100 µg/ml LPS, respectively; however, these results were not significantly different from LPS alone. Thus even though LPS stimulated NO production, inhibition of NO synthesis by three different inhibitors did not have the expected effect of blocking the LPS-induced relaxation. In addition, there was no significant effect of LPS or iNOS inhibitors on cell density or viability as determined by cell counts (data not shown).
Effect of LPS on contractility in iNOS-deficient lung pericytes. The ability of LPS to induce relaxation in pericytes lacking the iNOS gene was also demonstrated. LPS significantly reduced contractility of the pericytes in a concentration-dependent manner (Fig. 5 ) similar to that observed in control mice containing the iNOS gene (data not shown). At the highest concentration tested (100 µg/ml), LPS maximally reduced contraction by 45 Ϯ 10%, which is consistent with results obtained in the rat pericyte.
Aminoguanidine was still capable of somewhat potentiating the relaxation produced by LPS in iNOSdeficient pericytes; however, the response was not significantly different from that of LPS alone (Fig. 5) .
NO donor effect on pericyte contractility. Our initial hypothesis was that NO would mediate relaxation of pericytes; however, the enhanced relaxation of pericytes in the presence of NO synthesis inhibitors might suggest that instead of relaxing these cells, NO may actually modulate or mediate contraction in these cells. The ability of NO to contract gastrointestinal smooth muscle has been demonstrated by others (1) . Therefore, to determine whether NO is capable of either relaxing or contracting lung pericytes, contractility was measured in the presence of the NO donors SNP, SNAP, and spermine NONOate. At concentrations shown to produce relaxing effects in other studies (Ͻ10 Ϫ4 M; 11, 22, 24) , none of the NO donors had any effect on contractility (Fig. 6) . Only spermine NONOate at the highest concentration tested (10 Ϫ3 M) caused a significant reduction in contraction (to 32 Ϯ 4% of control).
The ability of bradykinin to contract these cells was also tested under conditions similar to those used in testing the NO donors. The response to bradykinin, known from previous experiments to be a pericyte contractile agent (30) , demonstrates that a contractile response of the cells in the collagen matrix, if present, can be measured. Bradykinin contracted these cells in a concentration-dependent manner, significantly increasing contraction by 50 Ϯ 16% at the highest concentration tested (Fig. 6) .
Effects of SNP on LPS-induced relaxation. Another possible explanation is that NO was only capable of affecting pericyte tension in the presence of LPS. To test this, SNP was added to LPS-treated cultures 10 min before release of the gels. As illustrated in Fig. 7 , the relaxation effect of LPS occurred regardless of the presence of SNP (10 Ϫ4 M). There was a nonsignificant trend toward increased relaxation in the presence of SNP, clearly indicating that this NO donor did not cause pericyte contraction.
DISCUSSION
This study demonstrates the ability of LPS and the inability of NO alone to induce relaxation of rat lung pericytes. LPS produced relaxation in a concentrationdependent manner that was apparent only after longterm incubation (24 h), suggesting intervening enzyme synthesis. Although LPS upregulated NO synthesis in the contractility assays, the LPS-induced relaxing effect was not blocked in the presence of the NOS inhibitors aminoguanidine, L-NAME, and L-NMMA and was still present in mouse pericytes derived from iNOS-deficient mice. Furthermore, the NO donors SNP, SNAP, and spermine NONOate at concentrations shown to affect contractility in other studies were unable to contract or relax the pericytes in this study. Therefore, although LPS induces lung pericyte relaxation and increases NO production, the two responses appear to be independent.
We considered the possibility that the presence of L-arginine (400 µM) in DMEM may interfere with the ability of competitive NOS inhibitors to effectively inhibit NO production. However, the presence of Larginine in DMEM has been previously shown to have no effect on phenylephrine-induced contractions in smooth muscle cells or on the ability of L-NAME and LPS (at these same concentrations) to affect phenylephrine-induced contractions (16, 31) . Furthermore, because aminoguanidine is a noncompetitive inhibitor of NOS (25) , its ability to inhibit induction of the NOS protein is independent of L-arginine (38) .
Aminoguanidine is capable of reducing NO in the LPS-treated cultures as well as in control (unstimulated) cultures. The ability of aminoguanidine to reduce NO levels in unstimulated cells suggests the presence of constitutive NOS (cNOS) protein in these cells, which has not been previously described in either pericytes or mesangial cells.
The ability of LPS to induce NO synthesis in this study is consistent with other in vitro studies involving . Each data point is mean percent contraction normalized over control value where control (no LPS, no inhibitor) is 100%. Values between control and L-NMMAϩLPS-treated wells (n ϭ 4) are significantly different (P Ͻ 0.001). At 50 and 100 µg/ml LPS, L-NMMA significantly potentiated the LPS response (* P Ͻ 0.05). B: results of 24-h incubation (n ϭ 5 wells) with L-NAME (10 µM) under same conditions as above. There was a significant difference between control value and L-NAMEϩLPS-treated cultures (P Ͻ 0.001); however, there was no significant difference between L-NAME-treated cultures and LPS alone (P Ͼ 0.05). both retinal pericytes and endothelial cells (5, 23) as well as smooth muscle cells (16) . In these studies, NO levels were increased ϳ20-fold; however, in the present study, NO levels are only increased twofold. Because induction of iNOS is responsible for production of excessive amounts of NO compared with cNOS, the ability of LPS to upregulate NO synthesis by only twofold in the present study again suggests the presence of a cNOS protein.
The inability of NOS inhibitors to attenuate LPSinduced relaxation has been previously reported in other tissues. In a study involving mammary artery and saphenous veins (31) , LPS attenuated the contractile response to phenylephrine, but L-NAME and L-NMMA were unable to attenuate this response in the saphenous veins, even at concentrations as high as 1 mM. A recent in vitro study (36) involving both endothelium-denuded aortic rings and vascular smooth muscle cells has also demonstrated a hypocontractile effect with LPS, which was only partially restored in the presence of a number of NOS inhibitors. Because aminoguanidine as well as L-NMMA exaggerated the LPS response in the present study, it is possible that these agents have other effects on contractile mechanisms, not previously described, that are independent of their effects on NO synthesis.
The ability of LPS in the present study to induce relaxation in iNOS-deficient mice clearly demonstrates that iNOS is not involved in mediating the LPS response. An in vivo study involving these iNOS-deficient mice (17) has also demonstrated a lack of iNOS involvement in mediating LPS-induced hypotension. In this study, LPS induced hypotension and death even in the complete absence of a functional iNOS gene. Further studies involving these iNOS-deficient mice could be useful in the elucidation of such iNOS-independent mechanisms.
In the present study, NO donors had little effect on contractility. This is in contrast to other studies involving both retinal pericytes and smooth muscle cells. In retinal pericytes, SNP at concentrations that produced no significant effect in the present study was shown to reduce basal tone and increase cGMP synthesis (11). , and spermine NONOate (C) on ability of rat lung pericytes to contract a collagen matrix after 10-min incubation in DMEM containing either bradykinin or NO donor and 15 µM BSA. Each data point is mean percent contraction normalized over control value where control is 100%. Both SNP and SNAP at indicated concentrations were unable to affect lung pericyte contractility (P Ͼ 0.3 and P Ͼ 0.9, respectively; n ϭ 3). C: effects of spermine NONOate on lung pericyte contractility. Effect of individual concentrations was only significant at 10 Ϫ3 M (P Ͻ 0.05, n ϭ 4). D: effect of bradykinin on contractility of pericytes (n ϭ 3). At a concentration of 10 Ϫ6 M, bradykinin increased contractility by 50 Ϯ 16%, which was significantly greater than control value (P Ͻ 0.03). Fig. 7 . Effect of SNP on ability of LPS to induce relaxation of rat lung pericytes after 24-h incubation (n ϭ 3 cultures) in DMEM containing LPS in absence and presence of SNP (10 Ϫ4 M). SNP was added 10 min before gels were detached from sides of well. Each data point is mean percent contraction normalized over control value where control (no LPS, no SNP) is 100%. There was a significant difference between control and SNPϩLPS-treated cultures (P Ͻ 0.007); however, there was no significant difference between SNP-treated cultures and LPS alone (P Ͼ 0.05).
cGMP is a known mediator of NO-dependent relaxation in many types of smooth muscle cells (12) . Similarly, SNAP (22) and spermine NONOate (24) at 10 Ϫ5 M have been shown to relax smooth muscle cells from various arteries. The only significant effect of a NO donor observed in the present study was with 10 Ϫ3 M spermine NONOate, which could have been due to nonspecific effects of the compound at this very high concentration. The inability of the lung pericyte to respond to NO may be a tissue-specific response and may indicate the lack of cGMP regulation of the contractile mechanism in the lung pericyte. The presence of tissue-specific responses has been previously shown to exist between various capillary beds (32) .
In addition to regulating vascular tone, NO has other postulated protective roles including inactivation of oxygen free radicals, prevention of microvascular thrombosis, inhibition of platelet aggregation, and adhesion to endothelial cells as well as stabilization of cell membranes (26) . Thus the inability of NO derived from lung pericytes to produce relaxation suggests the presence of another role for this LPS-induced NO.
The presence of a NO-independent /cGMP-independent relaxation pathway has also been shown to exist in cGMP kinase (cGKI)-deficient mice (21) . Because NOmediated relaxation occurs through activation of guanylate cyclase, loss of cGKI abolished NO-cGMPdependent relaxation of smooth muscle cells; however, cAMP-dependent relaxation was still present. cAMP has previously been demonstrated to relax retinal pericytes through disassembly of stress fibers (14) , and prior findings in our laboratory (30) have demonstrated that forskolin, an activator of adenylate cyclase, relaxes lung pericytes. Thus an alternative pathway that could mediate LPS-induced relaxation might involve cAMP.
In conclusion, although NO has been proposed to regulate vascular tone and play an important role in the hypocontractility associated with inflammatory conditions such as shock or sepsis, growing evidence exists that demonstrates the presence of NO-independent mechanisms associated with hypocontractility as well. This study demonstrates that LPS-mediated lung pericyte relaxation occurs by an iNOS-independent mechanism. Further studies of such iNOS-independent contractile responses are needed to better understand the mechanisms involved in regulating capillary hemodynamics.
